On June 27th, celebrity and cultural advocate Miss Lawrence returned to Atlanta with Plated Purpose, an immersive dining ...

Despite recent ASCO and FDA guidance recommending the inclusion of people living with HIV in pivotal cancer trials, nearly 75 ...

Anal cancer screening among men who have sex with men with HIV aged 35 years and older appeared cost-effective and could decrease anal cancer incidence and mortality, according to research published ...

Thirty-five years ago, the multimillion dollar fundraiser Seventh on Sale propelled the fashion industry into a new era of ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

By Dennis Thompson HealthDay ReporterFRIDAY, June 20, 2025 (HealthDay News) — A cheap HIV drug might be able to help people with diabetes reverse a complication that can lead to blindness, a new ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

Central Florida faces one of the highest HIV prevalence rates in the nation, with over 14,000 individuals currently living with the virus. Approximately 13% of those infected are unaware of their s… ...

HIV's route to infection is more flexible than previously believed, study finds by Emily Kagey, Morgan Sherburne, University of Michigan edited by Lisa Lock, reviewed by Robert Egan Editors' notes ...

Optimizing Background Therapy in Treatment-Experienced HIV-1 Patients by Rules-Based Algorithms and Bioinformatics Jenny Svärd; Anders Sönnerborg Disclosures Future Virology. 2012;7 (8):749-757.

The study, published in Nature Communications in May 2025, describes how scientists from the Peter Doherty Institute for Infection and Immunity developed a new lipid nanoparticle (LNP) called LNP X, ...

Worldwide, more than 3 million children are infected with HIV and, without treatment, mortality among these children is extremely high. Both acute and chronic malnutrition are major problems for ...